Trademark Search  /  DOPASTATIN

DOPASTATIN

○ Dead · Cancelled

U.S. federal trademark · Serial No. 78187797 · Reg. No. 023194670

Mark
DOPASTATIN
Status
Cancelled
Serial Number
78187797
Registration No.
023194670
Filing Date
November 19, 2002
Registration Date
November 19, 2002
Class(es)
Class 001, Class 005, Class 042

Owners

IPSEN PHARMA S.A.S.
11 · BOULOGNE-BILLANCOURT, FR
Societe de Conscils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
03 · Paris, FR
Societe de Conscils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
03 · Paris, FR
Societe de Conscils de Recherches et d'Applications Scientifiques (S.C.R.A.S.)
03 · Paris, FR

Goods & Services

Chemicals for use in the manufacture of pharmaceutical preparations

Research and development services for chemical and pharmaceutical products

Pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of gastrointestinal diseases; laxatives and purgative agents; pharmaceutical preparations for use in the treatment of cardiovascular diseases; pharmaceutical preparations for use in the treatment pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of neurological diseases; pharmaceutical preparations for use in the treatment of urological diseases;pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations comprising peptides for hormonal treatment and tumor treatment; pharmaceutical preparations for use in the treatment of endocrine disorders; pharmaceutical preparations for use in the treatment of acromegalia and carcinoid tumors; pharmaceutical preparations for use in the treatment of blood diseases; pharmaceutical preparations for use in the treatment of gastrointestinal bleeding disorders; pharmaceutical preparations for use in the treatment of muscle disorders; pharmaceutical preparations for use in the treatment of age-related disorders; pharmaceutical preparations for use in the treatment of diabetes, diabetes-related disorders; pharmaceutical preparations for use in the treatment of respiratory disorders; pharmaceutical preparations for use in the treatment of ophthalmological disorders; pharmaceutical preparations against cough; pharmaceutical preparations for use in the treatment of vertigo, nausea, vomiting and migraine; pharmaceutical preparations for use in the treatment of disorders and diseases of the reproductive system; pharmaceutical preparations for use in the treatment of glabellar lines, facial wrinkles, asymetries and defects and conditions of the human skin; and Veterinary preparations, namely, veterinary preparations for use in the treatment of gastrointestinal diseases; veterinary laxatives and purgative agent; veterinary preparations for use in the treatment of cardiovascular diseases; veterinary preparations for use in the treatment of circulatory disorders; veterinary preparations for use in the treatment of neurological diseases; veterinary preparations for use in the treatment of urological diseases; veterinary preparations for use in the treatment of blood diseases; and veterinary preparations for use in the treatment of muscle disorders

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "DOPASTATIN" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.